I don't think it got anything to do with bonusses or something like that. Would have been interesting to see a comparison with IMU. Comparing by EV, CHM is trading at about 1/40-50 of IMU's value. Got IMU really 40-50 times more to offer?
One thing is for sure, CHM is probably the most undervalued Bio-Stock on the ASX. And the data achieved so far are all at least competitive with existing drugs on the market, the GBM treatment even the world leader.
One day, one day........
About 11 weeks to CHMO expiry, 25.5c. If those would get " into the money " before 30 March '24 it would be a comeback to remember for ASX generations. But that's less likely than Jesus' second coming or the Socceroos winning the Asian Cup.
GLTA
CHM Price at posting:
3.4¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)